Swiss lawmakers are debating a proposal to lower the age threshold for state-subsidized preventative mammograms from 50 to 45, according to a parliamentary initiative filed by National Council member Michael Graber (SVP/VS). The policy shift aims to catch breast cancer earlier among women in their forties, where it represents the second-leading cause of death, though subsequent diagnostic costs remain a central point of contention in the legislative debate.
Lowering the Screening Age to 45
Under current Swiss cantonal screening programs, mandatory health insurance covers routine mammograms exclusively for women aged 50 to 74. Graber argues that this restriction ignores modern epidemiological data showing rising breast cancer incidence rates among women under 50. According to international data cited in Graber’s parliamentary proposal, routine screening starting at age 40 can reduce breast cancer mortality by approximately 25 percent. Furthermore, proponents argue that earlier detection limits ballooning treatment expenses associated with advanced stages of the disease.
The Financial Barrier of Follow-Up Examinations
While lawmakers broadly agree on expanding access, Brigitte Crottaz (SP/VD), a National Councillor and practicing physician, conditions her support on structural funding reforms for secondary diagnostics. Dense breast tissue is more common in younger women, meaning standard mammograms frequently fail to provide definitive results, according to Crottaz. When a screening yields suspicious findings, patients require secondary evaluations such as localized ultrasounds or magnetic resonance imaging (MRI).
These follow-up procedures currently fall outside the fully subsidized preventative framework. Crottaz points out that patients often face significant out-of-pocket costs due to standard insurance deductibles—frequently reaching 2,500 Swiss francs for otherwise healthy individuals—when investigating false alarms. Without reforms to cover these diagnostic steps under the standard 10 percent co-pay model used for initial mammograms, Crottaz warns that financial hurdles could deter younger women from participating in expanded screening programs.
Next Steps in Parliament
The Swiss Federal Council must now formally issue its position on Graber’s initial motion. Meanwhile, Crottaz is drafting a complementary parliamentary initiative to ensure that mandatory health insurance absorbs the costs of necessary diagnostic follow-ups if the screening age drops. The debate highlights an ongoing tension in healthcare policy between expanding preventative access and managing out-of-pocket diagnostic expenses for patients navigating cancer screenings.